Literature DB >> 10197974

Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.

T Durroux1, M Peter, G Turcatti, A Chollet, M N Balestre, C Barberis, R Seyer.   

Abstract

Fluoresceinyl and rhodamyl groups have been coupled by an amide link to side-chain amino groups at positions 1, 6, and 8 of pseudo-peptide linear vasopressin antagonists (Manning et al. Int. J. Pept. Protein Res. 1992, 40, 261-267) through different positions on the fluorophore, to give tetraethylrhodamyl-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2 (2), 4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Lys(5-carboxyfl uoresceinyl)-Pro-A rg-NH2 (4), 4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Lys(5- or 6-carboxytetramethylrhodamyl)-Pro-Arg-NH2 (5, 6), 4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5- or 6- carboxyfluoresceinyl)-NH2 (8, 9), and 4-HOPh(CH2)2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Lys(5- or 6- carboxytetramethylrhodamyl)-NH2 (10, 11). The closer to the C-terminus the fluorophore, the higher the affinities of the fluorescent derivatives for the human vasopressin V1a receptor transfected in CHO cells. The compound 10 has a Ki of 70 pM, as determined by competition experiments with [125I]-4-HOPhCH2CO-DTyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2. It showed a good selectivity for human V1a receptor versus human OT (Ki = 1.2 nM), human vasopressin V1b (Ki approximately 27 nM), and human vasopressin V2 (Ki > 5000 nM) receptor subtypes. All fluorescent analogues were antagonists as shown by the inhibition of vasopressin induced inositol phosphate accumulation. These fluorescent ligands are efficient for labeling cells expressing the human V1a receptor subtype, as shown by flow cytofluorometric experiments or fluorescence microscopy. They are also appropriate tools for structural analysis of the vasopressin receptors by fluorescence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197974     DOI: 10.1021/jm9804782

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.

Authors:  Laura Albizu; Martin Cottet; Michaela Kralikova; Stoytcho Stoev; René Seyer; Isabelle Brabet; Thomas Roux; Hervé Bazin; Emmanuel Bourrier; Laurent Lamarque; Christophe Breton; Marie-Laure Rives; Amy Newman; Jonathan Javitch; Eric Trinquet; Maurice Manning; Jean-Philippe Pin; Bernard Mouillac; Thierry Durroux
Journal:  Nat Chem Biol       Date:  2010-07-11       Impact factor: 15.040

2.  Influencing uptake and localization of aminoglycoside-functionalized peptoids.

Authors:  Melissa M Lee; Jonathan M French; Matthew D Disney
Journal:  Mol Biosyst       Date:  2011-05-24

Review 3.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

4.  Defining the RNA internal loops preferred by benzimidazole derivatives via 2D combinatorial screening and computational analysis.

Authors:  Sai Pradeep Velagapudi; Steven J Seedhouse; Jonathan French; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2011-06-09       Impact factor: 15.419

5.  Structural basis for the activation and ligand recognition of the human oxytocin receptor.

Authors:  Janosch Ehrenmann; Santiago Vacca; Cristian Thom; Yann Waltenspühl; Ohad Medalia; Andreas Plückthun
Journal:  Nat Commun       Date:  2022-07-18       Impact factor: 17.694

6.  Defining RNA motif-aminoglycoside interactions via two-dimensional combinatorial screening and structure-activity relationships through sequencing.

Authors:  Sai Pradeep Velagapudi; Matthew D Disney
Journal:  Bioorg Med Chem       Date:  2013-05-07       Impact factor: 3.641

Review 7.  Fluorescent agonists and antagonists for vasopressin/oxytocin G protein-coupled receptors: usefulness in ligand screening assays and receptor studies.

Authors:  B Mouillac; M Manning; T Durroux
Journal:  Mini Rev Med Chem       Date:  2008-09       Impact factor: 3.862

8.  Probing a 2-aminobenzimidazole library for binding to RNA internal loops via two-dimensional combinatorial screening.

Authors:  Sai Pradeep Velagapudi; Alexei Pushechnikov; Lucas P Labuda; Jonathan M French; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2012-09-14       Impact factor: 5.100

Review 9.  Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.

Authors:  M Manning; A Misicka; A Olma; K Bankowski; S Stoev; B Chini; T Durroux; B Mouillac; M Corbani; G Guillon
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

10.  BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues.

Authors:  Martin Cottet; Orestis Faklaris; Damien Maurel; Pauline Scholler; Etienne Doumazane; Eric Trinquet; Jean-Philippe Pin; Thierry Durroux
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-23       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.